Kit For The Preparation Of Technetium Tc 99m Medronate Injection, Powder, Lyophilized, For Solution
Product Images NDC 45567-0040

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Kit For The Preparation Of Technetium Tc 99m Medronate (NDC 45567-0040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (44b84192 4069 4300 9c17 54e31e949304 01)

FDA Label Image

5 Vial Container (44b84192 4069 4300 9c17 54e31e949304 02)

5 Vial Container (44b84192 4069 4300 9c17 54e31e949304 02)
This is a description of a medical product, used for intravenous treatment. It is a preservative containing Technetium Tc99m and does not contain bacteriostatic. The product is sterile, diagnostic, multi-dose and non-pyrogenic. The product is used only after labeling with oxidant-free Technetium Tc99m. The product contains medronic acid, ascorbic acid, and stannous fluoride. The pH is adjusted to 6.5 with NaOH and/or HCI prior to lyophilization. The recommended adult dose is 370-740 megabecquerels. It comes with package inserts for directions for use. The manufacturer is Sun Pharmaceutical Industries Inc. in Billerica, MA. The expiration date and lot number are also provided.*
FDA Label Image

Pl-000010 (44b84192 4069 4300 9c17 54e31e949304 03)

Pl-000010 (44b84192 4069 4300 9c17 54e31e949304 03)
This appears to be a description of a kit for the preparation of Technetium Tcs9m Medronate for injection. It includes information such as it being non-pyrogenic, sterile, and for diagnostic purposes. There are also storage instructions and recommended dosages given.*
FDA Label Image

Pl-000008 (44b84192 4069 4300 9c17 54e31e949304 04)

Pl-000008 (44b84192 4069 4300 9c17 54e31e949304 04)
This is a description of a medication used for injection labeled with Technetium Tc99m. It is a preservative that must be kept at a temperature of 20-25°C (68-77°F), and used within 6 hours after reconstitution. It contains medronic acid, ascorbic acid, stannous fluoride, and total tin in lyophilized form, and is sterile, diagnostic, multidose, and non-pyrogenic. The recommended adult dose is 370 - 740 megabecquerels (10-20 millicuries). The medication should only be used after labeling with oxidant-free Technetium Tc99m, and contains no bacteriostatic. Refer to the package insert for directions for use.*
FDA Label Image

30 Vial (44b84192 4069 4300 9c17 54e31e949304 05)

30 Vial (44b84192 4069 4300 9c17 54e31e949304 05)
This appears to be a label for a medical product. The product is called "Kit for the Preparation of Technetium Tc99m Medronate for Injection," and it is intended for diagnostic use. The label indicates that it is a sterile, non-pyrogenic, multi-dose product. The label also includes a lot number and expiration date.*
FDA Label Image

Pl 000009 Rev 0.1.jpg.jpg.jpg.jpg

Pl 000009 Rev 0.1.jpg.jpg.jpg.jpg
This is a cautionary text for a diagnostic, multidose kit used for intravenous injections. The kit contains 20 mg medronic acid, 1 mg ascorbic acid, 0.13 mg stannous fluoride, and 0.38 my total tin in lyophilized form. The pH is adjusted to 6.5 with NaOH and/or HCI prior to lyophilization. The solution must be labeled with Technetium Tc99m and used within 6 hours after reconstitution. The recommended adult dose is 370-740 megabecquerels. It is manufactured by a pharmaceutical company located in Melerica, MA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.